XII Jornada Mineira de Radiologia
Acesse o site do congresso
1º Dia - 6/19/26
2º Dia - 6/20/26

Casos clínicos desafiadores que o PET-CT pode auxiliar: do diagnóstico ao estadiamento Voltar

Mateus Furtado

Curso: Medicina Nuclear - Sessão 6 - Próstata: diagnóstico com PET-PSMA e PET-FDG - Lucas Candido e Pedro Henrique Furst Leite

Artigo Autor(es) Referência
A challenging diagnosis of prostate cancer seeding in the perineal needle-tract after transperineal biopsy: is PET-CT the imaging of choice? Fede Spicchiale Claudia, De Leonardis Federico, Orecchia Luca, Germani Stefano, Asimakopoulos Anastasios D, Miano Roberto Urology case reports. 2024 Nov; 57(Nov):102852. doi: 10.1016/j.eucr.2024.102852. pii: 102852.
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients. Ingvar Jacob, Hvittfeldt Erland, Trägårdh Elin, Simoulis Athanasios, Bjartell Anders EJNMMI research. 2022 Aug; 12(Aug):48. doi: 10.1186/s13550-022-00918-7. pii: 48.
Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge. Vetrone Luigia, Cuzzani Giulia, Mei Riccardo, Zanoni Lucia, Bertaccini Alessandro, Bianchi Lorenzo, Castellucci Paolo, Gaudiano Caterina, Cappelli Alberta, Giunchi Francesca, Fanti Stefano Frontiers in oncology. 2023 ; 13():1101221. doi: 10.3389/fonc.2023.1101221. pii: 1101221.
Current Clinical Applications of PSMA-PET for Prostate Cancer Diagnosis, Staging, and Treatment. von Stauffenberg Franz, Poyet Cédric, Beintner-Skawran Stephan, Maurer Alexander, Schmid Florian A Cancers. 2024 Dec; 16(Dec):doi: 10.3390/cancers16244263. pii: 4263.
Diagnostic Accuracy of PSMA-PET/CT vs. mpMRI in Primary Staging of Intermediate- and High-Risk Prostate Cancer. Talavera Cobo Vanessa, Yánez Ruiz Carlos Andres, Tapia Tapia Mario Daniel, Calva Lopez Andres, Muñoz Bastidas Carmina Alejandra, Ancizu Marckert Francisco Javer, Torres Roca Marcos, Huerta Luis Labairu, Sanchez Zalabardo Daniel, Diez-Caballero Alonso Fernando Jose, Guillen-Grima Francisco, Robles García Jose E, Miñana-López Bernardino Medical sciences (Basel, Switzerland). 2026 Jan; 14(Jan):doi: 10.3390/medsci14010064. pii: 64.
Efficacy of [18F]PSMA-1007 PET/CT in Primary Staging of Prostate Carcinoma: A Systematic Review and Metaanalysis. Rahbar Kambiz, Giesel Frederik L, Herrmann Ken, Yun Mijin, Watabe Tadashi, Rudolph Ines, Hoepping Alexander, Maurer Tobias Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2026 Jan; 67(Jan):85-91. doi: 10.2967/jnumed.125.269818. pii: .
Impact of piflufolastat F-18 PSMA PET imaging on clinical decision-making in prostate cancer across disease states: A retrospective review. Arafa Ali T, Jain Aditya, Skrobanek Pavel, Humphrey Brad, Froelich Jerry W, Antonarakis Emmanuel S The Prostate. 2023 Mar; doi: 10.1002/pros.24527. pii: .
PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer. Combes Alexander D, Palma Catalina A, Calopedos Ross, Wen Lingfeng, Woo Henry, Fulham Michael, Leslie Scott Diagnostics (Basel, Switzerland). 2022 Oct; 12(Oct):doi: 10.3390/diagnostics12112594. pii: 2594.
PSMA PET/CT for Primary Staging of Prostate Cancer - An Updated Overview. Jochumsen Mads Ryø, Bouchelouche Kirsten Seminars in nuclear medicine. 2024 Jan; 54(Jan):39-45. doi: 10.1053/j.semnuclmed.2023.07.001. pii: S0001-2998(23)00055-7.
PSMA PET/CT for prostate cancer diagnosis: current applications and future directions. Shen Zhengang, Li Zeng, Li Yunlong, Tang Xiaodi, Lu Jiayi, Chen Li, Cheng Zhu Zhong, Liao Hong, Zhou Shukui Journal of cancer research and clinical oncology. 2025 May; 151(May):155. doi: 10.1007/s00432-025-06184-z. pii: 155.
Prognostic value of [18F]FDG- and PSMA-PET in patients evaluated for [177Lu]Lu-PSMA therapy of mCRPC. Telli Tugce, Lopes Leonor, Karpinski Madeleine, Pabst Kim M, Grünwald Viktor, Shi Kuangyu, Hadaschik Boris, Kesch Claudia, Umutlu Lale, Herrmann Ken, Seifert Robert, Fendler Wolfgang P European journal of nuclear medicine and molecular imaging. 2025 Jul; 52(Jul):3199-3210. doi: 10.1007/s00259-025-07198-y. pii: .
Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences. van Altena Evelien J E, Jansen Bernard H E, Korbee Marieke L, Knol Remco J J, Luining Wietske I, Nieuwenhuijzen Jakko A, Oprea-Lager Daniela E, van der Pas Stéphanie L, van der Voort van Zyp Jochem R N, van der Zant Friso M, van Leeuwen Pim J, Wondergem Maurits, Vis André N European urology oncology. 2025 Apr; 8(Apr):417-424. doi: 10.1016/j.euo.2024.09.015. pii: S2588-9311(24)00224-4.
Treatment response assessment in mCRPC: is PSMA-PET/CT going to take the lead? Di Franco Martina, Mei Riccardo, Garcia Camilo, Fanti Stefano Therapeutic advances in medical oncology. 2024 ; 16():17588359241258367. doi: 10.1177/17588359241258367. pii: 17588359241258367.
Nenhuma revista foi definida para este congresso.